GLP-1 medications are reshaping how consumers shop, eat, and spend, creating ripple effects across categories. As adoption continues to rise, understanding the long-term impact requires looking beyond usage rates to the evolving behaviors that are driving structural changes in consumer demand.

On June 25 at 11 am CT, join Numerator’s Senior Director of Strategy & Enablement, Jenna Freese, as she explores the latest data on GLP-1 adoption, persistence, and behavioral shifts, revealing how these medications are influencing purchasing decisions, redefining consumption habits, and creating new opportunities for brands, retailers, and restaurants.

Register today to learn:

• How GLP-1 adoption and persistence are evolving—and why both matter when evaluating long-term impact
• The behavioral shifts consumers make throughout their GLP-1 journey
• Which categories are seeing the greatest gains and losses as demand is reallocated
• How GLP-1 users are redefining snacking, meal occasions, and restaurant visits
• Why persistence is the key factor determining whether today’s disruption becomes a lasting structural shift
• How leading brands and retailers are adapting through innovation, portfolio optimization, and occasion-based strategies